ClinicalTrials.Veeva

Menu

A Recurrence Nomogram for Hepatoid Adenocarcinoma of the Stomach

F

Fujian Medical University

Status

Completed

Conditions

Gastric Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT05274464
HAS-GC-01

Details and patient eligibility

About

This study aims to develop a nomogram to predict postoperative recurrence of HAS and guide individually tailored surveillance strategies.

Full description

Patients were included from the China Hepatoid Adenocarcinoma of the Stomach Study Group (China-HASSG) database, which comprises 14 tertiary referral centers. All the patients who had undergone complete resection of a primary HAS between April 2004 and December 2019 were included. First, univariate analysis was performed in Cox regression to identify the risk factors associated with RFS. Next, variables with P< 0.05 in univariable analysis were included in the multivariable model, and the forward likelihood ratio method was used for analysis to confirm the independent prognostic factors associated with RFS. Finally, based on the results of multivariable analysis, variables that achieved significance at P< 0.05 were selected to formulate a nomogram.

Enrollment

261 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients who had undergone complete resection of a primary HAS between April 2004 and December 2019

Exclusion criteria

  • Patients with metastatic disease, patients who had undergone palliative surgery, patients who had died within 30 days, and patients who were lost to follow-up

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems